Determination of ciprofloxacin in human serum by high-performance liquid chromatography;Dosage de la ciprofloxacine en milieu sérique par chromatographie liquide haute performance

Annales de Biologie Clinique

Volumn 63, Issue 5, 2005, Pages 513-516

  Bardot, S ^a   Vest, P ^a   Renard, C ^a   Renaudeau, C ^a  

^a PERCY MILITARY HOSPITAL   (France)

Author keywords

Ciprofloxacin; Drug monitoring; High performance liquid chromatography

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; QUINOLONE DERIVATIVE;

ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CALIBRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; SENSITIVITY AND SPECIFICITY; SPECTROFLUOROMETRY;

ANALYSIS OF VARIANCE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; FLUOROQUINOLONES; HUMANS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 30744471145     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Davis R, Markham A, Balfour JA. Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability. Drugs 1996 ; 51 : 1019-74.
2. Rohwedder R, Bergan T, Caruso E, Thorsteinsson SB, Della Torre H, Scholl H. Penetration of ciprofloxacin and metabolites into human lung, bronchial and pleural tissue after 250 and 500 mg oral ciprofloxacin. Chemotherapy 1991 ; 37 : 229-38.
3. Howden BP, Grayson ML. Hospital-in-the-home treatment of infectious diseases. Med J Aust 2002 ; 176 : 440-5.
4. Jim LK. Physical and chemical compatibility of intravenous ciprofloxacin with other drugs. Ann Pharmacother 1993 ; 27 : 704-7.
5. Goodwin SD, Nix DE, Heyd A, Wilton JH. Compatibility of ciprofloxacin injection with selected drugs and solutions. Am J Hosp Pharm 1991 ; 48 : 2166-71.
6. Overholser BR, Kays MB, Forrest A, Sowinski KM. Sex-related differences in the pharmacokinetics of oral ciprofloxacin. J Clin Pharmacol 2004 ; 44 : 1012-22.
7. Sowinski KM, Kays MB. Determination of ciprofloxacin concentrations in human serum and urine by HPLC with ultraviolet and fluorescence detection. J Clin Pharm Ther 2004 ; 29 : 381-7.
8. Imre S, Dogaru MT, Van CE, Muntean T, Kelemen L. Validation of an HPLC method for the determination of ciprofloxacin in human plasma. J Pharm Biomed Anal 2003 ; 33 : 125-30.
9. Kraemer HJ, Gehrke R, Breithaupt A, Breithaupt H. Simultaneous quantification of cefotaxime, desacetylcefotaxime, ofloxacine and ciprofloxacine in ocular aqueous humor and in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997 ; 700 : 147-53.
10. Krol GJ, Beck GW, Benham T. HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids. J Pharm Biomed Anal 1995 ; 14 : 181-90.
11. Kim DH, Lee SK, Park YH, Lee DW. Determination of ciprofloxacin and its metabolites in urine, using on-line SPE. J Liq Chrom Rel Technol 2002 ; 25 : 433-43.
12. Awni WM, Clarkson J, Guay DR. Determination of ciprofloxacin and its 7-ethylenediamine metabolite in human serum and urine by high-performance liquid chromatography. J Chromatogr 1987 ; 419 : 414-20.
13. Feinberg M. La validation des méthodes d'analyse. Paris : Masson, 1996.